技术文章

AkaLumine Hydrochloride: Near-IR Bioluminescence Substrate

AkaLumine hydrochloride is a synthetic, red-shifted analogue of firefly D-luciferin that enables near-infrared bioluminescence imaging with enhanced tissue penetration, making it a powerful tool for non-invasive in vivo studies in living animals.

Chemical Name
AkaLumine hydrochloride (also known as TokeOni·HCl)
Emission Wavelength
Near-infrared range (~675–700 nm with Fluc), red-shifted relative to native D-luciferin (~560 nm)
Primary Application
Non-invasive deep-tissue bioluminescence imaging in live animals
Compatible Enzyme
Firefly luciferase (Fluc) and engineered luciferase variants
Solubility
Soluble in aqueous buffers and DMSO; hydrochloride salt form improves aqueous solubility relative to free base
Supplier Reference
Aladdin SKU T487470; cross-reference Sigma 808350

What Is AkaLumine Hydrochloride?

AkaLumine hydrochloride (also marketed under the name TokeOni·HCl) is a synthetic luciferin analogue specifically designed to overcome a key limitation of the classical firefly bioluminescence system: the relatively short emission wavelength of native D-luciferin (~560 nm), which lies in a spectral region where biological tissues strongly absorb and scatter light.

By extending the π-conjugation of the luciferin scaffold, AkaLumine shifts the bioluminescent emission into the near-infrared (NIR) window (~675–700 nm when used with firefly luciferase, Fluc). Photons in this range experience substantially reduced absorption by hemoglobin and water, and markedly lower scattering by tissue, enabling signals to propagate through several centimetres of living tissue and be detected externally with high sensitivity.

The compound is supplied as the hydrochloride salt to enhance aqueous solubility, facilitating straightforward preparation of stock solutions in physiological buffers or DMSO for in vivo administration.

Mechanism of Action

Like all firefly luciferin analogues, AkaLumine undergoes an ATP- and Mg²⁺-dependent oxidative reaction catalysed by firefly luciferase (Fluc). The reaction proceeds in two steps:

  1. Adenylation: Luciferase activates AkaLumine by forming an AkaLumine-AMP intermediate, consuming one molecule of ATP.
  2. Oxidative decarboxylation: Molecular oxygen attacks the activated substrate, yielding an electronically excited oxyluciferin-analogue species. Relaxation of this excited state releases a photon in the NIR range, along with CO₂ and AMP.

The red-shifted emission relative to native D-luciferin arises from the extended conjugation of the AkaLumine chromophore, which lowers the energy gap between the excited and ground states of the product oxyluciferin analogue.

Importantly, AkaLumine retains sufficient affinity for wild-type Fluc to generate detectable bioluminescent signal, while also showing enhanced performance with certain engineered luciferase variants that have been optimised for red-shifted substrates, further boosting NIR photon output.

Key Applications in Research

AkaLumine hydrochloride is used across multiple areas of biomedical and life science research where conventional D-luciferin is limited by insufficient tissue penetration:

  • Deep-tissue in vivo bioluminescence imaging (BLI): Tumour xenograft studies, metastasis tracking, and cell-trafficking experiments in mice and rats benefit from the improved signal-to-background ratio achievable with NIR emission.
  • Neuroscience: Monitoring luciferase-expressing neurons or glial cells through the intact skull or overlying tissue, enabling longitudinal studies without surgical intervention.
  • Infectious disease models: Tracking luciferase-tagged pathogens (bacteria, viruses, parasites) in deep organs such as lungs, liver, and lymph nodes.
  • Stem cell and gene therapy research: Non-invasive, quantitative monitoring of cell engraftment, proliferation, and transgene expression over time.
  • Drug efficacy studies: Longitudinal assessment of tumour response to therapy using bioluminescent reporter cell lines, reducing the number of animals required per time point.

Because NIR photons penetrate tissue more efficiently, researchers can detect weaker or deeper signals that would be invisible using standard D-luciferin, improving sensitivity and reducing the need for high cell numbers or strong promoters.

Handling, Solubility, and Storage

Solubility and stock preparation: AkaLumine hydrochloride is soluble in aqueous buffers (e.g., PBS, pH 7.4) and in DMSO. Prepare stock solutions under subdued light to minimise photodegradation. For in vivo use, aqueous formulations in sterile saline or PBS are preferred; DMSO-based stocks should be diluted to a final DMSO concentration compatible with the animal model.

Storage: Store lyophilised or solid material at −20 °C, protected from light and moisture. Once reconstituted, aliquot and store at −20 °C; avoid repeated freeze-thaw cycles, which can reduce activity. Working solutions should be prepared fresh on the day of the experiment.

Handling precautions: Handle in accordance with standard laboratory safety practices. Wear appropriate personal protective equipment (gloves, lab coat, eye protection). Consult the Safety Data Sheet (SDS) for full hazard information before use.

Light sensitivity: Like other luciferin analogues, AkaLumine is light-sensitive. Keep vials wrapped in foil or use amber tubes during handling and incubation steps.

Ordering Information and Specifications

AkaLumine hydrochloride is available from Aladdin Scientific under SKU T487470. This product cross-references Sigma catalogue number 808350. Researchers should confirm purity, lot-specific certificate of analysis (CoA), and available pack sizes with Aladdin Scientific at the time of ordering to ensure the material meets the requirements of their specific assay.

When placing orders, consider the scale of planned experiments: bioluminescence imaging studies in rodents typically require milligram quantities per cohort. Contact Aladdin Scientific's technical support team for guidance on appropriate quantities, custom formulations, or bulk pricing.

All products are supplied with a CoA confirming identity and purity. For regulatory or quality-assurance purposes, SDS documents are available on request.

Frequently asked questions

How does AkaLumine hydrochloride differ from standard D-luciferin?

AkaLumine hydrochloride is a synthetic analogue of D-luciferin with an extended chromophore that shifts bioluminescent emission into the near-infrared range (~675–700 nm with Fluc), compared to ~560 nm for D-luciferin. This red-shifted emission improves tissue penetration and signal detection depth in living animals. The hydrochloride salt form also enhances aqueous solubility relative to the free base.

Is AkaLumine hydrochloride compatible with wild-type firefly luciferase?

Yes, AkaLumine hydrochloride is compatible with wild-type firefly luciferase (Fluc) and produces detectable bioluminescent signal. However, it may show enhanced performance when paired with engineered luciferase variants that have been optimised for red-shifted substrates. Researchers should empirically optimise substrate concentration for their specific luciferase construct and imaging system.

What is the recommended storage condition for AkaLumine hydrochloride?

Store the solid or lyophilised material at −20 °C, protected from light and moisture. Reconstituted solutions should be aliquoted and stored at −20 °C to avoid repeated freeze-thaw cycles. Working solutions should be prepared fresh on the day of use and kept protected from light throughout the experiment.

Can AkaLumine hydrochloride be administered in vivo, and by which routes?

AkaLumine hydrochloride has been used for in vivo bioluminescence imaging in rodent models. Common administration routes include intraperitoneal (i.p.) and intravenous (i.v.) injection of aqueous formulations in saline or PBS. The optimal dose and route should be determined empirically for each model; researchers should consult primary literature and institutional animal use guidelines for specific dosing parameters.

How should I prepare a working solution of AkaLumine hydrochloride?

Dissolve AkaLumine hydrochloride in sterile PBS or saline (pH 7.4) to prepare an aqueous stock solution, or use DMSO for higher-concentration stocks that will be diluted before use. Prepare solutions under subdued light, filter-sterilise if required for in vivo use, and use fresh solutions on the day of the experiment to ensure maximal activity.

References

  1. Iwano S, Obata R, Miura C, et al. Development of simple firefly luciferin analogs emitting blue, green, red, and near-infrared biological window light. Tetrahedron. 2013;69(14):3976-3984. doi:10.1016/j.tet.2013.03.050
  2. Mofford DM, Reddy GR, Miller SC. Aminoluciferins extend firefly luciferase bioluminescence into the near-infrared and can be preferred substrates over D-luciferin. J Am Chem Soc. 2014;136(38):13277-13282. doi:10.1021/ja505795s
  3. Sigma-Aldrich product page for AkaLumine hydrochloride, catalogue number 808350. Merck KGaA, Darmstadt, Germany.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

目录: 技术文章

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《AkaLumine Hydrochloride: Near-IR Bioluminescence Substrate》. 阿拉丁知识库,更新于 2026年10月23日。 https://www.aladdin-e.com/zh_cn/faqs/akalumine-hydrochloride-near-ir-bioluminescence-substrate-en.html
这篇文章对您有帮助吗? Yes No 有 1 人觉得有帮助